Cancer

Celcuity’s Phase 3 VIKTORIA-1 Trial Achieves Primary Endpoint With Clinically Meaningful Improvement in Progression-Free Survival in PIK3CA Mutant Cohort

Detailed data for the gedatolisib triplet and doublet regimens will be presented at a late-breaking abstract oral session at the...

Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies

Also Announces Extension of IR Program VANCOUVER, BC / ACCESS Newswire / May 1, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt:...

Suncoast Skin Solutions Founder Dr. Christopher Ewanowski to Lead Free Skin Cancer Screenings with BayCare on Melanoma Monday

Following a recent FSDPA speaking engagement, the Tampa-area dermatologist continues a spring schedule of community health initiatives and dermatology education...

The Preventative Care Crisis: HealthJoy’s Predictive Analytics Report Reveals Only 17% of Employees Plan to Complete Annual Physical Despite Rising Chronic and Complex Health Needs

Insights From 100,000+ Employees Nationwide Reveal Where Benefits Consultants and Employers Can Focus Interventions to Stem Escalating Healthcare Costs and...

CMS Is Quietly Pushing Unvalidated Hemp -Marijuana Products on America’s Elderly – and Calling It Healthcare

"Without clinical evidence, without public notice, and without congressional authorization, the federal government inserted psychoactive consumer products into Medicare -...

Cornerstone Specialty Network and Knowtex Announce Strategic Partnership to Advance AI-Driven Clinical Workflows and Operational Efficiency Nationwide

Collaboration to automate documentation, coding, and EMR workflows-reducing clinician burden, improving revenue performance, and enhancing patient care across community oncology...

XTL Biopharmaceuticals to Acquire Psyga Bio, Establishing a Leading Psychedelic Biotechnology Platform with Advanced Clinical Pipeline, Licensed GMP Manufacturing and Proprietary Psilocybin Technologies

Transaction Positions XTL at the Forefront of the Rapidly Expanding Global Psychedelic Therapeutics Market Following Major U.S. Regulatory Momentum Seven...

error: Content is protected !!